Comparison of nisoldipine and nifedipine as additional treatment in hypertension inadequately controlled by atenolol.

Author: EarleK A, HoffbrandB I, NievelJ G, RestrickL J, SimmondsN J

Paper Details 
Original Abstract of the Article :
Twenty-eight patients (11 Caucasian, 17 black) whose blood pressure was more than 160/96 mmHg after 4 weeks on placebo added to atenolol 100 mg/day were randomly given, in addition, nisoldipine 10 mg or nifedipine 20 mg each twice a day for 8 weeks in a double-blind cross-over study. There was a sta...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1136/pgmj.69.808.117

データ提供:米国国立医学図書館(NLM)

Nisoldipine vs. Nifedipine: A Comparison of Calcium Channel Blockers for Hypertension

[Hypertension] is a significant health concern affecting millions worldwide. This study compares the effectiveness of [nisoldipine] and [nifedipine], two [calcium channel blockers], as additional treatments for hypertension inadequately controlled by [atenolol]. The researchers conducted a double-blind crossover study to compare the efficacy and safety of nisoldipine and nifedipine in patients with hypertension.

Finding the Right Path to Lower Blood Pressure

The study found that both [nisoldipine] and [nifedipine] effectively lowered blood pressure in patients with hypertension inadequately controlled by [atenolol]. However, [nisoldipine] was associated with fewer adverse effects. It's like navigating the desert of hypertension, where choosing the right path can make all the difference in reaching a stable and healthy destination.

Tailoring Treatment for Individual Needs

This study emphasizes the importance of considering individual patient characteristics and potential side effects when choosing a [calcium channel blocker] for hypertension treatment. [Nisoldipine], with its higher coronary vascular selectivity and less negative inotropism, may be a suitable option for patients with impaired left ventricular function. It's like having a diverse range of desert plants, each with unique properties and benefits, allowing us to choose the most appropriate solution for specific needs.

Dr.Camel's Conclusion

This research highlights the potential of [nisoldipine] as a safe and effective [calcium channel blocker] for treating hypertension, particularly in patients with impaired left ventricular function. It underscores the importance of considering individual patient characteristics and potential side effects when choosing a medication for hypertension management.

Date :
  1. Date Completed 1993-07-07
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

8506191

DOI: Digital Object Identifier

10.1136/pgmj.69.808.117

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.